NUTEX HEALTH INC
NUTXNASDAQTrading Snapshot
- Day Range
- $298.77 β $302.45
- 52-Week Range
- $83.99 β $224.28
- Volume
- $1.74B
- Avg Volume
- $1.24B
- Shares Outstanding
- 6.9M
- Next Earnings
- Nov 28, 2026
Fundamentals Snapshot
- Annual Revenue
- $875M
- Last Q Revenue
- $211M
- P/E Ratio
- 8.1
- P/S Ratio
- 1.7x
- EPS (TTM)
- $26.19
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +40.7%
Why Investors Own NUTX
- βHigh-growth profile β revenue up +2.3% YoY with expanding US Equity exposure.
- βHealthy economics β 31% gross margin and 5% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
NUTEX HEALTH INC
NUTXAbout NUTEX HEALTH INC
Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
NUTEX HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift NUTX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
NUTEX HEALTH INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.